Showing 119 of 119on this page. Filters & sort apply to loaded results; URL updates for sharing.119 of 119 on this page
Imugene’s ASX IMU azer cel CAR T therapy trial shows encouraging ...
First Australian Patient Dosed in Phase 1b Trial of Imugenes Azer cel ...
Imugene secures FDA fast track designation for CAR T-cell therapy azer ...
Azercell reveals the “Victory Year”s results
Download Azercell Logo in SVG Vector or PNG File Format - Logo.wine
Unlock your Azercell iPhone for any sim card with a code or IMEI
Brand New: New Logo for Azercell
Azercell logo, Vector Logo of Azercell brand free download (eps, ai ...
Azercell Logo PNG Transparent – Brands Logos
Azercell logo displayed on hi-res stock photography and images - Alamy
Azercell - Azercell
Imugene says Azer-cel could be best-in-class Allogeneic CAR T - YouTube
Azercell Logo PNG Vector (SVG) Free Download
Precision Biosciences: Plenty Of Positive Updates; Waiting For The ...
About us | Azercell
Imugene (ASX: IMU) achieves a major milestone by dosing first patient ...
Azer-cel Trial Momentum Puts Imugene in the Spotlight
NWR Communications invites you to investor webinar on azer-cel ...
Imugene to showcase azer-cel data at major US healthcare conference ...
Imugene lifts response rate to 81% in azer-cel CAR T Phase 1b trial ...
Azercell Life
Imugene abstract on azer-cel selected for oral presentation at ASH 2025 ...
Imugene gets FDA backing for azer-cel treatment | ASX:IMU, OTC:IUGNF
Imugene, NeoImmuneTech to evaluate cancer cell therapy
Imugene (ASX: IMU)
Allogeneic CAR T Cell Therapy - Imugene Limited
Azer-cel Phase 1b Trial Shows 82% Response Rate in DLBCL Patients ...
Imugene enters new frontier with azer-cel CAR T therapy for blood ...
Imugene Reports Strong Results for Azer-cel in DLBCL Trial
Imugene Raises $37.5m to Advance Azer-Cel Clinical Trials for ...
Imugene Limited (ASX:IMU) FDA Fast Track for Azer-cel
Three Complete Responses in Azer-Cel Allogeneic CD19 CAR T Phase 1b ...
Azer-Cel Achieves Complete Responses in Relapsed/Refractory DLBCL
Imugene’s Azer-Cel Shows Promise in Relapsed/Refractory Diffuse Large B ...
FDA backs Imugene’s azer-cel treatment plan - ICYMI | ASX:IMU, OTC:IUGNF
New Allo CAR T-Cell Therapy for DLBCL Patients - HealthTree for Large B ...
Imugene's azer-cel shows strong results in Phase 1b trial for DLBCL ...
Imugene (ASX:IMU) shares soar on promising results from azer-cel Phase ...
Imugene doses first Australian patient in Phase 1b azer-cel clinical ...
Azer-Cel Produces CRs in R/R DLBCL After Prior Autologous CAR T-Cell ...
Imugene reports strong azer-cel data as clinical and regulatory ...
Allogeneic CAR T Azer-Cel Shows Early Activity Across B-Cell ...
Imugene reports strong early response rates for azer-cel in lymphoma ...
Azercell logo is displayed on smartphone. Azercell is an Azerbaijani ...
Imugene’s Azer-cel Advances in Phase 1b Trial for DLBCL Amidst Strong ...
Precision, Imugene conclude transaction for cancer treatment
Azercell Logo PNG Vector (AI) Free Download
Azercell, rotated logo, white background Stock Photo - Alamy
Azercell Logo, image, download logo | LogoWiki.net
Precision and TG Therapeutics conclude Azer-Cel license deal
Order free Azercell digital card!
Imugene’s Leslie Chong talks Azer-cel breakthrough | ASX:IMU, OTC:IUGNF
Imugene's first Australian patient dosed in Phase 1b azer-cel trial ...
Imugene Soars by Over 29% on Promising Azer-cel trial
Imugene doses first patient in US trial of Azer-cel allogeneic CAR T ...
Azercell on Behance
Allogeneic CAR-T Azer-Cel Achieves Complete Responses in Some Patients ...
The Market Wrap: Lithium Universe achieves near-Britannia silver purity ...
Administration of Low-Dose, Subcutaneous (SC) Interleukin-2 (IL-2 ...
Imugene welcomes positive FDA feedback on improved manufacturing ...
Imugene 报告 Azer-cel 在 1b 期试验中对晚期淋巴瘤患者有良好的结果 - 澳洲财经新闻 | 澳洲财经见闻 - 用资讯创造财富
Precision receives payments from TG Therapeutics for azer-cel
Imugene's azer-cel granted FDA Fast Track Designation in blood cancer ...
Azer-cel shows promise in treating aggressive blood cancer, CEO says ...
TG Therapeutics Receives Clearance from FDA for Phase 1 Trial in ...
Azer-cel granted FDA Fast Track Designation in DLBCL
Precision & TG Therapeutics: Unlocking Value With ARCUS, BRIUMVI And ...
Imugene opens first Australian site for azer-cel clinical trial ...
“Azercell Telecom” LLC offers “Subscriber identification” service free ...
Imugene (ASX: IMU) Advances Azer-cel Phase 1b Trial with Australian ...
Imugene raises $18.2m to fund azer-cel worldwide licencing deal
Azercell Kabinetim APK for Android - Download
Imugene posts 79% overall response rate in azer-cel Phase 1b trial ...
Azercell APK for Android Download
Imugene Limited on LinkedIn: We have received positive feedback from ...
Imugene Announces Outstanding Response Rates from the Phase 1b Trial of ...
Imugene Launches First Australian Site for Azer-cel Phase 1b Trial in ...
Azercell TEKNOFEST 2022 » Stend.az
Azercell Kabinetim | Your Azercell, your application
Imugene Limited: Azer-cel Achieves Significant Progress in Phase 1b CAR ...
“Azercell” xidmətlərini 50 faiz bahalaşdırdı - SİYAHI
Azercell Logo Azend Healing (@azendhealing) • Facebook
Imugene raises A$2.42M in SPP to go towards azer-cel program | ASX:IMU ...
MaxCyte & TG Therapeutics Partner to Advance Azer-cel for Autoimmune ...
Imugene’s Phase 1b Azer-cel trial 57% complete response rate | Proactive
Azercell has started gradual activation of the digital card!
Imugene, a clinical‑stage immuno‑oncology company, has unveiled ...
Imugene welcomes positive FDA feedback on new manufacturing process for ...
"Azercell"ə bağlı "ASAN İmza"lar iflic vəziyyətdə Pravda.az
Azercell Müştəri Xidmətləri: Effektiv Əlaqə Kanalları İlə Məmnuniyyət ...
Azercell is now officially certified as Great Place to Work®
Imugene (ASX: IMU) gets FDA support for azer-cel manufacturing process
FDA Grants Azer-Cel Fast Track Status in DLBCL
Azercell continues the gradual activation of its digital card for pre ...
Azercell satışa çıxarıla bilər - Oxu.az
Суперпризы и сюрпризы от Azercell в честь 23-летия компании - InfoCity
Listening to Dr. Maakaron, an investigator on our azer-cel program ...
FDA Approves Precision BioSciences, Inc.'s CMC Strat for Late-Stage ...
Azercell 2024 Poster :: Behance
Imugene Reports Encouraging Efficacy from Phase Ib Azer-cel Trial in DLBCL
“Azercell”in törəmə şirkətinin rəhbəri dəyişib - təyinat